Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2007. Start Trial.
Date Value
November 13, 2026 7.627
November 12, 2026 7.627
November 11, 2026 7.627
November 10, 2026 7.627
November 09, 2026 7.627
November 06, 2026 7.627
November 05, 2026 7.627
November 04, 2026 7.627
November 03, 2026 7.627
November 02, 2026 7.627
October 30, 2026 7.627
October 29, 2026 7.627
October 28, 2026 7.627
October 27, 2026 7.627
October 26, 2026 7.627
October 23, 2026 7.627
October 22, 2026 7.627
October 21, 2026 7.627
October 20, 2026 7.042
October 19, 2026 7.042
October 16, 2026 7.042
October 15, 2026 7.042
October 14, 2026 7.042
October 13, 2026 7.042
October 12, 2026 7.042
Date Value
October 09, 2026 7.042
October 08, 2026 7.042
October 07, 2026 7.042
October 06, 2026 6.478
October 05, 2026 6.478
October 02, 2026 6.478
October 01, 2026 6.520
September 30, 2026 6.374
September 29, 2026 6.374
September 28, 2026 6.374
September 25, 2026 6.374
September 24, 2026 6.785
September 23, 2026 6.785
September 22, 2026 6.785
September 21, 2026 6.785
September 18, 2026 6.785
September 17, 2026 6.785
September 16, 2026 6.785
September 15, 2026 6.785
September 14, 2026 6.785
September 11, 2026 6.785
September 10, 2026 6.785
September 09, 2026 6.785
September 08, 2026 6.785
September 04, 2026 7.923

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Novo Nordisk A/S 5.558
H. Lundbeck A/S 1.930
AstraZeneca PLC 12.05
ANI Pharmaceuticals, Inc. 2.550
Corcept Therapeutics, Inc. 9.079

Price to Book Value Related Metrics